LSL Pharma Group Inc.
LSL.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.64M | 205.90K | 205.70K | 121.40K | 211.20K |
| Total Receivables | 3.82M | -- | 3.45M | 2.51M | 2.39M |
| Inventory | 9.08M | -- | 6.34M | 4.16M | 3.88M |
| Prepaid Expenses | 486.90K | -- | 699.20K | 509.30K | 738.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.03M | -- | 10.69M | 7.31M | 7.22M |
|
|
|||||
| Total Current Assets | 17.03M | -- | 10.69M | 7.31M | 7.22M |
| Net Property, Plant & Equipment | 17.87M | -- | 15.94M | 14.01M | 13.14M |
| Long-term Investments | 115.10K | -- | 109.10K | -- | -- |
| Goodwill | 115.10K | -- | 109.10K | -- | -- |
| Total Other Intangibles | 10.09M | -- | 9.22M | 6.76M | 6.63M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 207.50K | -- | 1.23M | 14.80K | 14.60K |
| Total Assets | 45.31M | -- | 37.19M | 28.10M | 27.00M |
|
|
|||||
| Total Accounts Payable | 5.51M | -- | 3.13M | 2.60M | 2.75M |
| Total Accrued Expenses | -- | -- | 480.90K | -- | -- |
| Short-term Debt | 6.59M | -- | 1.78M | 380.50K | 496.10K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.20M | -- | 1.32M | 3.29M | 3.55M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 13.31M | -- | 6.71M | 6.26M | 6.80M |
|
|
|||||
| Total Current Liabilities | 13.31M | -- | 6.71M | 6.26M | 6.80M |
| Long-Term Debt | 9.74M | -- | 8.86M | 4.83M | 4.22M |
| Short-term Debt | 6.59M | -- | 1.78M | 380.50K | 496.10K |
| Capital Leases | 3.06M | -- | 3.08M | 1.90M | 1.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.31M | -- | 1.24M | 24.40K | 30.70K |
| Total Liabilities | 27.42M | -- | 19.89M | 13.02M | 12.77M |
|
|
|||||
| Common Stock & APIC | 28.95M | -- | 27.41M | 29.17M | 27.86M |
| Retained Earnings | -11.34M | -- | -10.37M | -14.37M | -13.90M |
| Treasury Stock & Other | 275.00K | -- | 260.60K | 277.60K | 274.00K |
| Total Common Equity | 17.89M | 17.32M | 17.30M | 15.08M | 14.23M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.89M | 17.32M | 17.30M | 15.08M | 14.23M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.89M | 17.32M | 17.30M | 15.08M | 14.23M |
|
|
|||||